COVID-19 leads to venous thromboembolism by establishing a generalized hypercoagulable state, with elevated plasma levels of key clotting factors including fibrinogen, factors V and VIII, as well as von Willebrand factor (vWF), which is a multidomain plasma protein essential for both platelet adhesion and aggregation [7]. This evidence concerns the gene VWF and COVID-19.